TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

QILU ANTIBIOTICS

Infectious DiseaseDermatology
Generics

QILU ANTIBIOTICS is a generic drug manufacturer focused on Infectious Disease, Dermatology. Key products include CEFAZOLIN SODIUM.

2015
Since
4
Drugs
-
Trials
9
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

CEFAZOLIN SODIUM 2026-02-13
Efficacy
CEFAZOLIN SODIUM 2025-12-01
Manufacturing (CMC)
CEFAZOLIN SODIUM 2025-08-21
Labeling
CEFAZOLIN SODIUM 2025-08-21
Labeling
CEFAZOLIN SODIUM 2025-08-21
Labeling
CEFAZOLIN SODIUM 2024-12-18
Efficacy
ERTAPENEM SODIUM 2024-10-31
ERTAPENEM SODIUM 2024-06-13
Labeling
CEFEPIME HYDROCHLORIDE 2024-05-22
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 60%
3 drugs
Dermatology 40%
2 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Infectious Disease, Dermatology
Baxter specialty
Infectious Disease, Dermatology
B BRAUN specialty
Infectious Disease, Dermatology
COSETTE other
Dermatology, Infectious Disease
BAUSCH AND LOMB specialty
Infectious Disease, Dermatology